APOE4 structural biology and therapeutic targeting strategies

PARTIALLY ADDRESSED

APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.

Priority: 0.91 Domain: neurodegeneration Hypotheses: 16
📊 Landscape Analysis

Landscape Summary: APOE4 structural biology and therapeutic targeting strategies is a 0.91 priority gap in neurodegeneration. It has 16 linked hypotheses with average composite score 0.738. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

APOE4 structural biology and therapeutic targeting strategies — INVOKE-2 (completed)

📈 Living Dashboards
16
Hypotheses
0.795
Top Score
0.738
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTAC
Target: APOE Pathway: Apolipoprotein E lipid transpo
0.795
score
Competitive APOE4 Domain Stabilization Peptides
Target: APOE Pathway: Apolipoprotein E lipid transpo
0.784
score
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid Sensing an
Target: TREM2, APOE Pathway: lipid metabolism, amyloid clea
0.774
score
APOE4 Allosteric Rescue via Small Molecule Chaperones
Target: APOE Pathway: Apolipoprotein E lipid transpo
0.765
score
Targeted APOE4-to-APOE3 Base Editing Therapy
Target: APOE Pathway: Apolipoprotein E lipid transpo
0.758
score
APOE Isoform Expression Across Glial Subtypes
Target: APOE Pathway: Lipid Metabolism / Cholesterol
0.743
score
APOE4-Selective Lipid Nanoemulsion Therapy
Target: APOE Pathway: APOE-mediated cholesterol/lipi
0.742
score
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Target: APOE Pathway: Apolipoprotein E lipid transpo
0.723
score
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Target: APOE4 Pathway: APOE-mediated cholesterol/lipi
0.682
score
APOE4-Lipid Metabolism Correction
Target: APOE Pathway: APOE-mediated cholesterol/lipi
0.610
score
🌊 Knowledge Graph Connections

activates (11)

APOE4NeurodegenerationALZHEIMER'S DISEASEAPOE4ALZHEIMERAPOE4AMYLOIDAPOE4APOE3APOE4
▸ Show 6 more

associated with (16)

APOE4APOEAPOE4AlzheimerAPOE4Alzheimer's diseaseAPOE4AgingALZHEIMERAPOE4
▸ Show 11 more

biomarker for (1)

APOE4alzheimer_disease

causes (1)

APOE4Blood-Brain Barrier Dysfunction

disrupts (1)

APOE4intracellular lipid homeostasis

downregulates (1)

APOE4lipid_droplet_biogenesis

encodes (1)

APOE4APOE4

expressed in (4)

APOE4AlzheimerAPOE4APOEALZHEIMER'S DISEASEAPOE4ALZHEIMERAPOE4

increases risk (2)

APOE4alzheimer_diseaseAPOE4alzheimers

inhibits (3)

APOE4microglial_activationAPOE4neurodegenerative microglia responseAPOE4PINK1/Parkin axis

predicts (1)

APOE4cognitive decline

promotes (1)

APOE4seizure susceptibility

regulates (3)

APOE4NeuroinflammationAPOE4InflammationAPOE4Neurodegeneration

relates to (1)

h-immunity-c64967abAPOE4

risk factor for (2)

APOE4late-onset Alzheimer's diseaseAPOE4Late-Onset Alzheimer Disease

therapeutic target (1)

APOE4Alzheimer
🕑 Activity Feed
update on knowledge_gap by codex 2026-04-21T12:53
📈 Competitive APOE4 Domain Stabilization Peptides score=0.784 2026-04-02T01:34
📈 APOE4 Allosteric Rescue via Small Molecule Chaperones score=0.765 2026-04-02T01:34
📈 Targeted APOE4-to-APOE3 Base Editing Therapy score=0.758 2026-04-02T01:34
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps